Followers | 1610 |
Posts | 118764 |
Boards Moderated | 20 |
Alias Born | 08/20/2006 |
Wednesday, September 12, 2018 4:54:14 PM
(“GROUP”), a German-based public-company whose stock trades on the Frankfurt Exchange under ISIN DE 000A14KR27/
WKN A14KR2, representing a minority interest in the outstanding GROUP shares as of the date of this Information Statement.
GROUP’s software and consulting business was focused on serving IBM’s Lotus Notes and Domino market. GROUP provided
IBM Lotus Notes/Domino Application and Transformation technology. Headquartered in Karlsruhe, Germany, GROUP had
offices throughout Europe and North America and maintained a website at www.gbs-ag.com. The information contained on
GROUP’s website is not incorporated by reference herein
Recent MRZM News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/06/2024 09:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:55:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/29/2023 10:15:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 01:06:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 11:02:41 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/22/2023 09:36:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 09:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 11:08:53 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:27:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/24/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 01:08:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 01:15:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/18/2023 04:15:10 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/17/2023 09:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 01:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 09:12:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:15:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 08:05:53 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 12:59:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/31/2023 12:57:08 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/18/2023 08:59:08 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 07/12/2023 08:26:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM